Pricing Log in Create free account

Repligen Corporation (RGEN) vs ResMed Inc. (RMD)

Repligen Corporation and ResMed Inc. are both Medical Instruments & Supplies companies. ResMed Inc. is the larger, with a market value of $34.1B against $11.7B — 2.9× the size. ResMed Inc. trades at the lower P/E: 22.8× against 234×. Repligen Corporation grew revenue faster over the last twelve months: 16.5% against 9.85%. ResMed Inc. has the higher net margin (26.9% vs 5.29%) and the higher return on invested capital (21.4% vs 2.18%). Across the 22 metrics below, ResMed Inc. leads on 16 and Repligen Corporation on 6.

Valuation

Metric RGEN RMD Medical Instruments & Supplies median
P/E 233.60 22.85 33.75
P/S 12.59 6.15 2.52
P/B 4.68 5.28 2.48
Price to free cash flow 161.81 21.35 25.19
EV/EBITDA 60.20 15.82 14.62
EV/Sales 12.35 5.96 2.88
Earnings yield 0.43% 4.38% (2.67%)
Free cash flow yield 0.62% 4.68% 0.09%

Profitability

Metric RGEN RMD Medical Instruments & Supplies median
Gross margin 53.52% 61.06% 54.29%
Operating margin 8.23% 33.37% 1.07%
Net margin 5.29% 26.94% (1.61%)
Free cash flow margin 14.06% 28.81% 1.08%
Return on equity 1.99% 24.27% (1.32%)
Return on assets 1.42% 17.77% 0.00%
Return on invested capital 2.18% 21.38% 0.00%

Growth

Metric RGEN RMD Medical Instruments & Supplies median
Revenue growth (TTM) 16.49% 9.85% 8.85%
EPS growth (last fiscal year) 286.96% 9.67% 8.65%
Revenue growth, 5-year CAGR 15.05% 12.08% 9.17%
Net income growth, 5-year CAGR (3.99%) 26.27% 0.00%

Health

Metric RGEN RMD Medical Instruments & Supplies median
Debt to equity 0.26 0.06 0.10
Current ratio 9.05 3.10 2.48
Net debt to EBITDA (1.50) (0.50) 0.89

Dividend

Metric RGEN RMD Medical Instruments & Supplies median
Dividend yield — 1.03% 1.11%
Payout ratio — 0.24 0.27

Size

Metric RGEN RMD Medical Instruments & Supplies median
Market cap 11.69b 34.07b 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack